Governance
What can we learn from Apple’s 250$ win of the watch patent lawsuit?
Apple recently won its patent lawsuit against Masimo, making headlines across all media platforms. I found the $250 award and the spokesperson’s statements—”we’re not here for money” and “stop copying our design”—especially intriguing. This portrayal makes Apple seem like an artist frustrated by som…
Headline
Apple recently won its patent lawsuit against Masimo, making headlines across all media platforms. I found the $250 award and the spokesperson’s statements—”we’re not here for money” and “stop copying our design”—especially intriguing. This portrayal makes Apple seem like an…
Context
Apple recently won its patent lawsuit against Masimo, making headlines across all media platforms. I found the $250 award and the spokesperson’s statements—”we’re not here for money” and “stop copying our design”—especially intriguing. This portrayal makes Apple seem like an artist frustrated by someone copying their work. It also highlights the exhaustion of their ongoing patent battles.The issue mirrors current debates about AI using copyrighted artwork to generate images, but I won’t delve into that topic here. According to USPTO patent statistics for 2023, China filed 4.23 times more patent applications than the U.S., showcasing its ambition in research and development (R&D). Design and utility patents dominate the filings, with a slight increase from 2022 to 2023, totaling 146. The United States remains a leader in intellectual property protection, attracting innovations and experts to build a strong patent system.
Evidence
Pending intelligence enrichment.
Analysis
In utility patents, Samsung leads in filings, reflecting its extensive technology portfolio. For design patents, Nike significantly surpasses Apple, filing more than twice as many. Among Nike’s domestic and global patents, 82% remain active, according to a July 2024 report by Insight & Stats. Many designs from other companies have faced rejection due to Nike’s patent lawsuits. Apple’s ongoing legal battle with Masimo dates back to 2013. They are contesting the inclusion of blood oxygen sensors (pulse oximetry technology) in the Apple Watch. Masimo sued Apple for patent violation, accusing the company of infringing on its utility patent. As a result, Apple had to withdraw the Apple Watch Series 9 and Ultra 2 from the market. However, Apple has reintroduced these models without the blood oxygen measuring feature after losing the case earlier this year. In October, a sales and import ban was imposed on Apple, but recently, the company secured a $250 statutory minimum in a design patent trial against Masimo. The jury sided with Apple, stating that Masimo allegedly copied its design for the W1 Freedom and health model. Masimo contended that the design application only relates to chargers, not the products currently on the market. This countersuit reflects Apple’s attempt to mitigate delays in launching its watch products. Despite this small victory, Apple’s efforts to lift the ban remain limited, as the recent verdict was not in its favor, and it largely failed in the patent infringement cases filed. Masimo focuses on oximetry technology and produces medical devices for various health sectors. Their non-invasive monitoring technology appears in all their products, covering personal health, parenting, and fitness. This entire product line relies on clinical research studies, showcasing industry-leading pulse oximetry technology. Pulse oximetry serves as a crucial metric for indicating oxygen deprivation, which can lead to serious diseases. Their innovative technology enhances patient health tracking and improves overall care quality. Masimo’s pulse oximetry technology outperforms competitors by delivering accurate readings promptly and while in motion. It effectively addresses challenges in measuring low perfusion and avoids overestimating arterial oxygenation for darker-skinned patients. Thus, pulse oximetry technology essentially serves as Masimo’s signature product. Apple’s violation of this technology grants Masimo the right to defend its utility patent. The patent violation cases against Apple highlight the competitive nature of the health-tech wearable market. Apple faces the challenge of maintaining its market position with renewed product lines each year. Industrial giants feel increased pressure to remain innovation leaders while addressing these sustainability challenges.
Key Points
- Apple recently won 250$ from a patent lawsuit from Masimo, a medical device maker based in Irvine.
- Apple’s long tug of patent violation with Masimo is over the utility patent of pulse oximetry technology.
- Apple sued 181 times over patent infringement in the past 5 years.
Actions
Pending intelligence enrichment.
